“Global Coalition On Aging” Launches as 450 Million People Turn 65 Over Next Two Decades

Greater Longevity is a Call to Action for Governments, Industry, Global Institutions

NEW YORK (Jan. 26, 2011) – The Global Coalition on Aging announced its launch today as a pioneering new initiative to raise awareness and address the social and economic impact of global population aging. Founding members are AEGON, Bank of America Merrill Lynch, Galderma, Intel, Johnson & Johnson, Novartis, Nutricia, Pfizer, and Universal American Corp. Deloitte Consulting LLP is serving as an advisory member.

The Global Coalition on Aging will provide leadership, research, and advocacy to help nations and industry advance sustainable solutions that address the unprecedented demographic transformation already underway. The Coalition is unique in its focus on aging’s impact on all aspects of life and society: the workplace, health, and long-term financial security.

“The emergence of the Coalition is tremendously exciting and fills a critical need at a critical time,” said Dr. John Beard, Director of Ageing and Life Course for the World Health Organization. “It is unique, not just in the breadth of its interests in aging, but also in its philosophy that the best approach is for people to remain engaged and productive as they grow older. We look forward to working closely with the Coalition to press for change in the policy arena.”

The Coalition will foster a re-shaping of public policies to align to the new demographic realities. Over the next three years, the Coalition will roll out a strategic plan to drive social and policy changes in four key areas:

  • Education and work
  • Financial planning and security
  • Health and wellness
  • Technology, innovation, and biomedical research

“We will share this plan with business, governments and other stakeholders who want to join us in this important new venture,” said Coalition Executive Director Michael Hodin. “We will advance innovative solutions to improve health and wellness, expand work opportunities, and provide ongoing education and financial planning to turn what could be a fiscal and political crisis into platforms for economic growth and intergenerational collaboration.”

It is estimated that there will be two billion people over the age of 60 by mid-century, and they will outnumber children for the first time in history. “These demographic realities call for far-reaching work, lifestyle, business, and governmental changes,” said Nicholas Eberstadt, demographer and Henry Wendt Chair in Political Economy at the American Enterprise Institute. “We are still living with public policies and social infrastructures that were designed for a different time with different demographics.”

In the United States alone, the number of people over 65 will double from 40 million today to 89 million – one in every five Americans – by 2050. Similar shifts are underway across the globe, though the pace of change differs from country to country. Populations in Europe, Japan and South Korea are further along the aging curve, while countries like China and India, which have younger populations, will experience the aging phenomenon a generation or two later.

According to Baroness Sally Greengross, a Member of the UK House of Lords and President of the International Longevity Centre United Kingdom, the Coalition is making “a great contribution with its optimistic view of aging. These leading global companies are committed to helping this generation and the next live differently, more productively and with greater fulfillment for themselves and society, into their eighties and beyond.”

“As the longevity miracle shapes the 21st century, the Global Coalition on Aging is well positioned to draw upon the best corporate strategies, partner with stakeholders across society and work with governments and policymakers to promote pragmatic solutions,” Hodin said.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.